A postmarketing surveillance study of the safety and efficacy of ReFacto (St Louis-derived active substance) in patients with haemophilia A. [electronic resource]
Producer: 20061108Description: 444-51 p. digitalISSN:- 1351-8216
- Adolescent
- Adult
- Aged
- Blood Coagulation Factor Inhibitors -- blood
- Child
- Child, Preschool
- Drug Administration Schedule
- Factor VIII -- adverse effects
- Hemophilia A -- complications
- Hemorrhage -- etiology
- Hemostasis, Surgical -- methods
- Humans
- Infant
- Male
- Middle Aged
- Product Surveillance, Postmarketing
- Recombinant Proteins -- adverse effects
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.